CARDIFF, WALES, UK – TrakCel, the leading provider of cellular orchestration technology to aid in the delivery of regenerative therapies, has successfully completed a multi-million

Precision NanoSystems, Inc. (PNI), a global nanomedicine company, has announced the completion of a $13.4 million private Series A financing. The investment was led by

FREMONT, Calif.– (BUSINESS WIRE)–Nitinol Devices & Components, Inc. (“NDC”), announced today it has successfully completed the acquisition of Interface Catheter Solutions (“Interface”). Reflecting the combination’s

Mountain View, CA—December 4, 2014—/PRNewswire/—PneumRx, Inc. (www.pneumrx.com), a leader in the field of interventional pulmonology, today announced that it has signed an agreement to be

Acquisition makes Horizon the world’s leading gene-editing and translational genomics company Highlights Horizon acquires Sage Labs Inc. for up to $48M (£29M) comprising up to

Colorado Springs, Colo., June 30, 2014 (GLOBE NEWSWIRE)—The Spectranetics Corporation (Nasdaq:SPNC) today announced that it has completed the acquisition of AngioScore Inc., a leading developer,

John Lillig to Lead Agena Bioscience as Chairman and Interim CEO San Diego, Calif., May 30, 2014—Agena Bioscience, Inc., a portfolio company of Telegraph Hill

Former Life Technologies’ Head of Strategy & Corporate Development Expands Firm’s Technology, Business Strategy and Operating Expertise San Francisco, February 10, 2014—Telegraph Hill Partners (THP),

WEST CHESTER, Ohio—(BUSINESS WIRE)—Jan. 2, 2014—AtriCure, Inc. (Nasdaq: ATRC), a leading Atrial Fibrillation medical device provider, today announced the completion of the previously announced acquisition

AUSTIN, Texas, Oct. 8, 2013 (GLOBE NEWSWIRE) – LDR Holding Corporation (Nasdaq:LDRH) (“LDR” or the “Company”), a global medical device company focused on designing and

Vidacare Corporation to be acquired by TeleflexVidacare Corporation of San Antonio, Texas has entered into a merger agreement to be acquired by Teleflex Incorporated. San

San Francisco, July 29, 2013 – Telegraph Hill Partners (THP), a leading venture capital and growth equity firm dedicated exclusively to life science and healthcare